Aria Clinic S.R.L.
- Address
- lock Available on a paid plan
Neurology Clinical Trial Research
At Aria Clinic S.R.L. in Sibiu, the clinical research focus is centered on nervous system diseases, with studies exploring both chronic neuroinflammatory conditions and neurodegenerative disorders. The trials are designed to evaluate new treatment options, assess safety and tolerability, and better understand how therapies may support patients’ daily functioning and long-term outcomes.
- Research in multiple sclerosis, especially relapsing multiple sclerosis, is examining whether new therapies can help reduce relapses and support disease control.
- Studies in Alzheimer’s disease are focused on people with mild cognitive impairment or mild dementia, aiming to improve cognition and preserve function.
- Work in generalized myasthenia gravis is assessing whether investigational treatment approaches can improve symptom control and overall clinical benefit.
Overall, the site’s neurology portfolio reflects a strong interest in testing potential therapies for complex neurological conditions, with an emphasis on treatment effectiveness and patient-centered outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Merck Healthcare KGaA1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Aria Clinic S.R.L.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, 3-Period Study to Assess the Efficacy and Safety of a New Formulation of Oral Cladribine Compared with Placebo in Participants with Generalized Myasthenia Gravis (MyClad) | Merck Healthcare KGaA | Phase III | Recruiting | Nov 2024 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Semaglutide | 2 | Unknown | 2021-05-17 | 2021-05-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.